These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Immuno suppressive drugs in the treatment of myasthenia (author's transl)]. Buscaino GA Riv Patol Nerv Ment; 1974 Aug; 95(4):399-410. PubMed ID: 4377801 [No Abstract] [Full Text] [Related]
30. Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus. Kakisaka Y; Haginoya K; Yokoyama H; Ishitobi M; Wakusawa K; Sato I; Togashi N; Kitamura T; Fukuyo N; Yoshihara Y; Iinuma K Brain Dev; 2006 Sep; 28(8):534-6. PubMed ID: 16564661 [TBL] [Abstract][Full Text] [Related]
31. Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients? Wong SH; Plant GT; Cornblath W J Neuroophthalmol; 2016 Mar; 36(1):98-102. PubMed ID: 26218625 [No Abstract] [Full Text] [Related]
32. [Therapy of myasthenia gravis]. Jerusalem F Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820 [No Abstract] [Full Text] [Related]
33. [Myasthenia gravis--diagnosis, therapy and special problems]. Tackenberg B; Gellert K; Kruth J; Oertel WH; Sommer N MMW Fortschr Med; 2008 May; 150 Suppl 2():68, 70-2. PubMed ID: 18678057 [No Abstract] [Full Text] [Related]
34. [Immunosuppressive therapy of myasthenias]. Mertens HG; Hertel G Med Welt; 1973 Jun; 24(23):955-63. PubMed ID: 4355431 [No Abstract] [Full Text] [Related]